Annual Accounts Payable
$4.29 B
-$312.00 M-6.77%
31 December 2023
Summary:
Abbott Laboratories annual accounts payable is currently $4.29 billion, with the most recent change of -$312.00 million (-6.77%) on 31 December 2023. During the last 3 years, it has risen by +$349.00 million (+8.84%). ABT annual accounts payable is now -6.77% below its all-time high of $4.61 billion, reached on 31 December 2022.ABT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$4.03 B
-$91.00 M-2.21%
30 September 2024
Summary:
Abbott Laboratories quarterly accounts payable is currently $4.03 billion, with the most recent change of -$91.00 million (-2.21%) on 30 September 2024. Over the past year, it has increased by +$73.00 million (+1.84%). ABT quarterly accounts payable is now -15.20% below its all-time high of $4.76 billion, reached on 31 March 2022.ABT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABT Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.8% | +1.8% |
| 3 y3 years | +8.8% | +0.4% |
| 5 y5 years | +44.4% | +33.2% |
ABT Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -6.8% | +8.8% | -15.2% | +1.8% |
| 5 y | 5 years | -6.8% | +44.4% | -15.2% | +33.2% |
| alltime | all time | -6.8% | +1286.4% | -15.2% | +1202.1% |
Abbott Laboratories Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.03 B(-2.2%) |
| June 2024 | - | $4.13 B(-1.3%) |
| Mar 2024 | - | $4.18 B(-2.7%) |
| Dec 2023 | $4.29 B(-6.8%) | $4.29 B(+8.4%) |
| Sept 2023 | - | $3.96 B(-5.9%) |
| June 2023 | - | $4.21 B(+1.1%) |
| Mar 2023 | - | $4.17 B(-9.6%) |
| Dec 2022 | $4.61 B(+4.5%) | $4.61 B(+11.5%) |
| Sept 2022 | - | $4.13 B(-8.0%) |
| June 2022 | - | $4.49 B(-5.5%) |
| Mar 2022 | - | $4.76 B(+7.9%) |
| Dec 2021 | $4.41 B(+11.7%) | $4.41 B(+9.7%) |
| Sept 2021 | - | $4.02 B(0.0%) |
| June 2021 | - | $4.02 B(-1.2%) |
| Mar 2021 | - | $4.07 B(+3.0%) |
| Dec 2020 | $3.95 B(+21.3%) | $3.95 B(+23.7%) |
| Sept 2020 | - | $3.19 B(-4.4%) |
| June 2020 | - | $3.33 B(+4.8%) |
| Mar 2020 | - | $3.18 B(-2.2%) |
| Dec 2019 | $3.25 B(+9.3%) | $3.25 B(+7.4%) |
| Sept 2019 | - | $3.03 B(-6.0%) |
| June 2019 | - | $3.22 B(+5.8%) |
| Mar 2019 | - | $3.04 B(+2.4%) |
| Dec 2018 | $2.98 B(+23.9%) | $2.98 B(+9.0%) |
| Sept 2018 | - | $2.73 B(+9.1%) |
| June 2018 | - | $2.50 B(+1.1%) |
| Mar 2018 | - | $2.48 B(+3.1%) |
| Dec 2017 | $2.40 B(+103.9%) | $2.40 B(+29.3%) |
| Sept 2017 | - | $1.86 B(+11.5%) |
| June 2017 | - | $1.67 B(+12.6%) |
| Mar 2017 | - | $1.48 B(+25.7%) |
| Dec 2016 | $1.18 B(+9.0%) | $1.18 B(+12.1%) |
| Sept 2016 | - | $1.05 B(-8.8%) |
| June 2016 | - | $1.15 B(+9.5%) |
| Mar 2016 | - | $1.05 B(-2.6%) |
| Dec 2015 | $1.08 B(+1.6%) | $1.08 B(+7.3%) |
| Sept 2015 | - | $1.01 B(+0.7%) |
| June 2015 | - | $1.00 B(-1.2%) |
| Mar 2015 | - | $1.01 B(-4.9%) |
| Dec 2014 | $1.06 B(+3.7%) | $1.06 B(+10.3%) |
| Sept 2014 | - | $965.00 M(-9.1%) |
| June 2014 | - | $1.06 B(-1.1%) |
| Mar 2014 | - | $1.07 B(+4.7%) |
| Dec 2013 | $1.03 B(-42.9%) | $1.03 B(+1.7%) |
| Sept 2013 | - | $1.01 B(-3.2%) |
| June 2013 | - | $1.04 B(-4.2%) |
| Mar 2013 | - | $1.09 B(-39.5%) |
| Dec 2012 | $1.80 B(+4.4%) | $1.80 B(+11.9%) |
| Sept 2012 | - | $1.61 B(+5.6%) |
| June 2012 | - | $1.52 B(-12.0%) |
| Mar 2012 | - | $1.73 B(+0.3%) |
| Dec 2011 | $1.72 B(+12.1%) | $1.72 B(+7.4%) |
| Sept 2011 | - | $1.60 B(+10.6%) |
| June 2011 | - | $1.45 B(-8.2%) |
| Mar 2011 | - | $1.58 B(+2.7%) |
| Dec 2010 | $1.54 B(+19.9%) | $1.54 B(+0.3%) |
| Sept 2010 | - | $1.53 B(-5.2%) |
| June 2010 | - | $1.62 B(-2.9%) |
| Mar 2010 | - | $1.66 B(+29.9%) |
| Dec 2009 | $1.28 B(-5.2%) | $1.28 B(-8.2%) |
| Sept 2009 | - | $1.39 B(+17.7%) |
| June 2009 | - | $1.19 B(+0.1%) |
| Mar 2009 | - | $1.18 B(-12.3%) |
| Dec 2008 | $1.35 B(+10.8%) | $1.35 B(+10.4%) |
| Sept 2008 | - | $1.22 B(+3.7%) |
| June 2008 | - | $1.18 B(-3.9%) |
| Mar 2008 | - | $1.23 B(+0.7%) |
| Dec 2007 | $1.22 B | $1.22 B(+5.6%) |
| Sept 2007 | - | $1.15 B(+8.8%) |
| June 2007 | - | $1.06 B(+7.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2007 | - | $987.51 M(-16.0%) |
| Dec 2006 | $1.18 B(+13.9%) | $1.18 B(+18.1%) |
| Sept 2006 | - | $995.34 M(-4.0%) |
| June 2006 | - | $1.04 B(+11.4%) |
| Mar 2006 | - | $930.82 M(-9.8%) |
| Dec 2005 | $1.03 B(-2.1%) | $1.03 B(+0.2%) |
| Sept 2005 | - | $1.03 B(+9.3%) |
| June 2005 | - | $942.60 M(-4.5%) |
| Mar 2005 | - | $986.64 M(-6.4%) |
| Dec 2004 | $1.05 B(-2.2%) | $1.05 B(-34.0%) |
| Sept 2004 | - | $1.60 B(+7.6%) |
| June 2004 | - | $1.49 B(-5.7%) |
| Mar 2004 | - | $1.57 B(+46.1%) |
| Dec 2003 | $1.08 B(-35.1%) | $1.08 B(-18.2%) |
| Sept 2003 | - | $1.32 B(-11.4%) |
| June 2003 | - | $1.49 B(-8.1%) |
| Mar 2003 | - | $1.62 B(-2.6%) |
| Dec 2002 | $1.66 B(+8.9%) | $1.66 B(+87.2%) |
| Sept 2002 | - | $887.80 M(-14.9%) |
| June 2002 | - | $1.04 B(+2.6%) |
| Mar 2002 | - | $1.02 B(-33.3%) |
| Dec 2001 | $1.53 B(+12.5%) | $1.53 B(-2.2%) |
| Sept 2001 | - | $1.56 B(+2.7%) |
| June 2001 | - | $1.52 B(+4.4%) |
| Mar 2001 | - | $1.45 B(+7.2%) |
| Dec 2000 | $1.36 B(+10.5%) | $1.36 B(+7.3%) |
| Sept 2000 | - | $1.26 B(-14.6%) |
| June 2000 | - | $1.48 B(+23.0%) |
| Mar 2000 | - | $1.20 B(-1.9%) |
| Dec 1999 | $1.23 B(+16.0%) | $1.23 B(+3.0%) |
| Sept 1999 | - | $1.19 B(+43.4%) |
| June 1999 | - | $830.75 M(-21.5%) |
| Mar 1999 | - | $1.06 B(+0.1%) |
| Dec 1998 | $1.06 B(+5.6%) | $1.06 B(+14.6%) |
| Sept 1998 | - | $922.34 M(-1.1%) |
| June 1998 | - | $932.49 M(-1.1%) |
| Mar 1998 | - | $942.59 M(-5.8%) |
| Dec 1997 | $1.00 B(+8.5%) | $1.00 B(+22.1%) |
| Sept 1997 | - | $819.88 M(-10.0%) |
| June 1997 | - | $911.44 M(-5.7%) |
| Mar 1997 | - | $966.85 M(+4.8%) |
| Dec 1996 | $923.00 M(+22.1%) | $923.00 M(+17.1%) |
| Sept 1996 | - | $788.09 M(-2.3%) |
| June 1996 | - | $806.29 M(+13.7%) |
| Mar 1996 | - | $709.15 M(-6.2%) |
| Dec 1995 | $755.92 M(+12.6%) | $755.92 M(+13.5%) |
| Sept 1995 | - | $665.93 M(-11.7%) |
| June 1995 | - | $754.27 M(+11.1%) |
| Mar 1995 | - | $678.81 M(+1.1%) |
| Dec 1994 | $671.10 M(+5.1%) | $671.10 M(+13.3%) |
| Sept 1994 | - | $592.48 M(-18.2%) |
| June 1994 | - | $724.47 M(+20.2%) |
| Mar 1994 | - | $602.83 M(-5.6%) |
| Dec 1993 | $638.51 M(+6.9%) | $638.51 M(+25.3%) |
| Sept 1993 | - | $509.60 M(+4.9%) |
| June 1993 | - | $485.60 M(-3.2%) |
| Mar 1993 | - | $501.60 M(-16.0%) |
| Dec 1992 | $597.20 M(+14.3%) | $597.20 M(+34.8%) |
| Sept 1992 | - | $443.00 M(+1.3%) |
| June 1992 | - | $437.30 M(+1.1%) |
| Mar 1992 | - | $432.70 M(-17.2%) |
| Dec 1991 | $522.40 M(+48.7%) | $522.40 M(+43.7%) |
| Sept 1991 | - | $363.50 M(-2.5%) |
| June 1991 | - | $372.80 M(+5.0%) |
| Mar 1991 | - | $355.10 M(+1.1%) |
| Dec 1990 | $351.20 M(+13.4%) | $351.20 M(+12.1%) |
| Sept 1990 | - | $313.40 M(+1.0%) |
| June 1990 | - | $310.30 M(-3.6%) |
| Mar 1990 | - | $322.00 M(+3.9%) |
| Dec 1989 | $309.80 M | $309.80 M |
FAQ
- What is Abbott Laboratories annual accounts payable?
- What is the all time high annual accounts payable for Abbott Laboratories?
- What is Abbott Laboratories annual accounts payable year-on-year change?
- What is Abbott Laboratories quarterly accounts payable?
- What is the all time high quarterly accounts payable for Abbott Laboratories?
- What is Abbott Laboratories quarterly accounts payable year-on-year change?
What is Abbott Laboratories annual accounts payable?
The current annual accounts payable of ABT is $4.29 B
What is the all time high annual accounts payable for Abbott Laboratories?
Abbott Laboratories all-time high annual accounts payable is $4.61 B
What is Abbott Laboratories annual accounts payable year-on-year change?
Over the past year, ABT annual accounts payable has changed by -$312.00 M (-6.77%)
What is Abbott Laboratories quarterly accounts payable?
The current quarterly accounts payable of ABT is $4.03 B
What is the all time high quarterly accounts payable for Abbott Laboratories?
Abbott Laboratories all-time high quarterly accounts payable is $4.76 B
What is Abbott Laboratories quarterly accounts payable year-on-year change?
Over the past year, ABT quarterly accounts payable has changed by +$73.00 M (+1.84%)